Skip to main content
SpringerLink
Log in

Structural and neurochemical evaluation of the brain and pons in patients with Wilson’s disease

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

An Erratum to this article was published on 26 January 2011

Abstract

Purpose

The aim of this study was to examine the structural-neurochemical abnormalities of the frontal white matter (FWM), deep gray matter nuclei, and pons in patients with Wilson’s disease (WD) using proton magnetic resonance spectroscopy (MRS) and diffusion-weighted imaging (DWI).

Materials and methods

Nine patients with WD and 14 age-matched controls were examined with MRS. N-Acetylaspartate (NAA), choline (Cho), and creatine (Cr) peaks were calculated. DWI scans from six WD patients and six controls were also obtained. The relative metabolite ratios and apparent diffusion coefficient (ADC) values of the WD patients were compared to those of the control subjects by using statistical measures.

Results

Measurements in the thalamus and pons showed significantly lower NAA/Cho and NAA/Cr ratios in the WD group than in the control group (P < 0.05). Thalamic and pontine Cho/Cr ratios in the patient group were significantly higher than those of the control group (P < 0.05). No statistically significant relation was found between the patient and control groups as a result of the MRS examinations of FWM and all ADC measurements (P > 0.05).

Conclusion

MRS is a noninvasive, valuable modality for detecting structural-neurochemical changes of the brain stem and deep gray matter in patients with WD. The contribution of DWI in these patients is limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tarnacka B, Szeszkowski W, Golebiowski M, Czlonkowska A. MR spectroscopy in monitoring the treatment of Wilson’s disease patients. Mov Disord 2008;23:1560–1566.

    Article  PubMed  Google Scholar 

  2. Tarnacka B, Szeszkowski W, Buettner J, Golebiowski M, Gromadzka G, Czlonkowska A. Heterozygous carriers for Wilson’s disease: magnetic spectroscopy changes in the brain. Metab Brain Dis 2009;24:463–468.

    Article  CAS  PubMed  Google Scholar 

  3. Alanen A, Kamu M, Penttinen M, Leino R. Magnetic resonance imaging and proton MR spectroscopy in Wilson’s disease. Br J Radiol 1999;72:749–756.

    CAS  PubMed  Google Scholar 

  4. Kraft E, Trenkwalder C, Bergh FT, Auer DP. Magnetic resonance proton spectroscopy of the brain in Wilson’s disease. J Neurol 1999;246:693–699.

    Article  CAS  PubMed  Google Scholar 

  5. Van Wassenaer-van Hall HN, van den Heuvel AG, Jansen GH, Hoogenraad TU, Mali WP. Cranial MR in Wilson disease: abnormal white matter in extrapyramidal and pyramidal tracts. AJNR Am J Neuroradiol 1995;16:2021–2027.

    PubMed  Google Scholar 

  6. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, et al. Wilson’s disease: cranial MRI observations and clinical correlation. Neuroradiology 2006;48:613–621.

    Article  CAS  PubMed  Google Scholar 

  7. Saatci I, Topcu M, Baltaoglu FF, Köse G, Yalaz K, Renda Y, et al. Cranial MR findings in Wilson’s disease. Acta Radiol 1997;38:250–258.

    CAS  PubMed  Google Scholar 

  8. King AD, Walshe JM, Kendall BE, Chinn RJ, Paley MN, Wilkinson ID, et al. Cranial MR imaging in Wilson’s disease. AJR Am J Roentgenol 1996;167:1579–1584.

    Article  CAS  PubMed  Google Scholar 

  9. Bican A, Bora I, Algin O, Hakyemez B, Ozkol V, Alper E. Neuroimaging in narcolepsy. Sleep Med 2010;11:225–226.

    Article  CAS  PubMed  Google Scholar 

  10. Soares DP, Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 2009;64:12–21.

    Article  CAS  PubMed  Google Scholar 

  11. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331–345.

    Article  CAS  PubMed  Google Scholar 

  12. Page RA, Davie CA, MacManus D, Miszkiel KA, Walshe JM, Miller DH, et al. Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease. Neurology 2004;63:638–643.

    Article  CAS  PubMed  Google Scholar 

  13. Lucato LT, Otaduy MC, Barbosa ER, Machado AA, McKinney A, Bacheschi LA, et al. Proton MR spectroscopy in Wilson disease: analysis of 36 cases. AJNR Am J Neuroradiol 2005;26:1066–1071.

    PubMed  Google Scholar 

  14. Kizkin S, Sarac K, Ozisik HI, Ozcan C. Central pontine myelinolysis in Wilson’s disease: MR spectroscopy findings. Magn Reson Imaging 2004;22:117–121.

    Article  CAS  PubMed  Google Scholar 

  15. Sener RN. Diffusion MRI findings in Wilson’s disease. Comput Med Imaging Graphics 2003;27:17–21.

    Article  CAS  Google Scholar 

  16. Juan CJ, Chen CY, Liu YJ, Chung HW, Chin SC, Hsueh CJ, et al. Acute putaminal necrosis and white matter demyelination in a child with subnormal copper metabolism in Wilson disease: MR imaging and spectroscopic findings. Neuroradiology 2005;47:401–405.

    Article  PubMed  Google Scholar 

  17. Da Costa MD, Spitz M, Bacheschi LA, Leite CC, Lucato LT, Barbosa ER. Wilson’s disease: two treatment modalities: correlations to pretreatment and posttreatment brain MRI. Neuroradiology 2009;51:627–633.

    Article  Google Scholar 

  18. Kalra V, Mahajan S, Kesarwani PK. Rare presentation of Wilson’s disease: a case report. Int Urol Nephrol 2004;36:289–291.

    Article  PubMed  Google Scholar 

  19. Shannon KM. Movement disorders. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, editors. Neurology in clinical practice. 4th edn. vol 2. Philadelphia: Butterworth Heinemann; 2004. p. 2159–2160.

    Google Scholar 

  20. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson’s disease. Lancet 2007;369:397–408.

    Article  CAS  PubMed  Google Scholar 

  21. Pfeiffer RF. Wilson’s disease. In: Watts RL, Koller WC, editors. Movement disorders. 2nd edn. New York: McGraw-Hill; 2004. p. 779–797.

    Google Scholar 

  22. Machado AA, Deguti MM, Genschel J, Cançado EL, Bochow B, Schmidt H, et al. Neurological manifestations and ATP7B mutations in Wilson’s disease. Parkinsonism Relat Disord 2008;14:246–249.

    Article  PubMed  Google Scholar 

  23. Mak CM, Lam CW. Diagnosis of Wilson’s disease: a comprehensive review. Crit Rev Clin Lab Sci 2008;45:263–290.

    Article  CAS  PubMed  Google Scholar 

  24. Demirkiran M, Jankovic J, Lewis RA, Cox DW. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology 1996;46:1040–1043.

    Article  CAS  PubMed  Google Scholar 

  25. Ross ME, Jacobson IM, Dienstag JL, Martin JB. Late-onset Wilson’s disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol 1985;17:411–413.

    Article  CAS  PubMed  Google Scholar 

  26. Czlonkowska A, Rodo M, Gromadzka G. Late onset Wilson’s disease: therapeutic implications. Mov Disord 2008;23:896–898.

    Article  PubMed  Google Scholar 

  27. Czlonkowska A, Tarnacka B, Möller JC, Leinweber B, Bandmann O, Woimant F, et al. Unified Wilson’s disease rating scale: a proposal for the neurological scoring of Wilson’s disease patients. Neurol Neurochir Pol 2007;41:1–12.

    PubMed  Google Scholar 

  28. Van Den Heuvel AG, Van Der Grond J, Van Rooij LG, Van Wassenaer-van Hall HN, Hoogenraad TU, Mali WPTM. Differentiation between portal-systemic encephalopathy and neu rodegenerative disorders in patients with Wilson’s disease: H-1 MR spectroscopy. Radiology 1997;203:539–543.

    Google Scholar 

  29. Jayasundar R, Sahani AK, Gaikwad S, Singh S, Behari M. Proton MR spectroscopy of basal ganglia in Wilson’s disease: case report and review of literature. Magn Reson Imaging 2002;20:131–135.

    Article  PubMed  Google Scholar 

  30. Tarnacka B, Szeszkowski W, Golebiowski M, Czlonkowska A. Metabolic changes in 37 newly diagnosed Wilson’s disease patients assessed by magnetic resonance spectroscopy. Parkinsonism Relat Disord 2009;15:582–586.

    Article  CAS  PubMed  Google Scholar 

  31. Yurtsever I, Hakyemez B, Taskapilioglu O, Erdogan C, Turan OF, Parlak M. The contribution of diffusion-weighted MR imaging in multiple sclerosis during acute attack. Eur J Radiol 2008;65:421–426.

    Article  PubMed  Google Scholar 

  32. Favrole P, Chabriat H, Guichard P, Woimant F. Clinical correlates of cerebral water diffusion in Wilson disease. Neurology 2006;66:384–389.

    Article  CAS  PubMed  Google Scholar 

  33. Smith AB, Smirniotopoulos JG, Rushing EJ, Goldstein SJ. Bilateral thalamic lesions. AJR Am J Roentgenol 2009;192:W53–62.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Atatürk Training and Research Hospital, Ankara, Turkey

    Oktay Algin

  2. National Magnetic Resonance Research Center, Ankara, Turkey

    Oktay Algin

  3. Department of Neurology, Uludag University Medical Faculty, Gorukle, Bursa, Turkey

    Ozlem Taskapilioglu, Sukran Yurtogullari & Sevda Erer

  4. Department of Radiology, Uludag University Medical Faculty, Gorukle, Bursa, Turkey

    Bahattin Hakyemez & Mufit Parlak

  5. Department of Biostatistics, Uludag University Medical Faculty, Gorukle, Bursa, Turkey

    Gokhan Ocakoglu

Authors
  1. Oktay Algin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozlem Taskapilioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bahattin Hakyemez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gokhan Ocakoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sukran Yurtogullari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sevda Erer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mufit Parlak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oktay Algin.

Additional information

An erratum to this article can be found online at http://dx.doi.org/10.1007/s11604-010-0546-6

About this article

Cite this article

Algin, O., Taskapilioglu, O., Hakyemez, B. et al. Structural and neurochemical evaluation of the brain and pons in patients with Wilson’s disease. Jpn J Radiol 28, 663–671 (2010). https://doi.org/10.1007/s11604-010-0491-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-010-0491-4

Key words

Search

Navigation